Carbamazepine, a drug initially used for the treatment of seizure disorders, is currently being investigated for its usefulness with psychiatric patients. Affectively disturbed patients in particular have received attention. This article presents three clinical vignettes of patients helped by carbamazepine and suggests future research directions.
Get full access to this article
View all access options for this article.
References
1.
DalbyM., Behavioral Effects of Carbamazepine, in Advances in NeurologyVol. II, PenryJ. and DalyD. (eds.), Raven Press, New York, 1975.
2.
FolksD.KingD.DowdyS., Carbamazepine Treatment of Selective Affectively Disordered Inpatients, American Journal of Psychiatry, 139, pp. 115–117, 1982.
3.
BallengerJ. and PostR., Carbamazepine in Manic-Depressive Illness, A New Treatment, American Journal of Psychiatry, 137, pp. 782–790, 1980.
4.
OkumaT.KishimotoA.InoueK., Anti-Manic and Prophylactic Effects of Carbamazepine (Tegretol) on Manic Depressive Psychosis, Frolia Psychiatrica et Neurologica Japonica, 27: 4, pp. 283–297, 1973.
5.
OkumaT., Therapeutic and Prophylactic Effects of Carbamazepine in Bipolar Disorders, Psychiatric Clinics of North America, 6: 1, AkiskalH. (ed.), Saunders, Philadelphia, 1983.
6.
HelleksonC.BucklandR., and PriceT., Organic Personality Disturbance: A Case of Apparent Atypical Cyclic Affective Disorder, American Journal of Psychiatry, 136, pp. 833–835, 1979.
7.
BlumerD. and BensonD., Personality Changes with Frontal and Temporal Lobe Lesions, in Psychiatric Aspects of Neurological Disease, BensonD. and BlumerD. (eds.), Grune and Stratton, New York, 1975.
8.
BearD. and FedioP., Quantitative Analysis of Interictal Behavior in Temporal Lobe Epilepsy, Archives of Neurology, 34, pp. 454–467, 1977.
